Iveric Bio to Present Zimura® GATHER2 Enrollment and Retention Updates and New GATHER1 Post-Hoc Analyses Today at its Dry Age-Related Macular Degeneration Virtual Symposium for Investors
– GATHER2 Enrollment Nears Completion; Timeline Accelerated to Late July of this Year – –